GRIN2D Gene Early Infantile Epileptic Encephalopathy Type 46 Genetic Test
Test Name: GRIN2D Gene Early Infantile Epileptic Encephalopathy Type 46 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for GRIN2D Gene Early Infantile Epileptic Encephalopathy Type 46 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GRIN2D Gene Early Infantile Epileptic Encephalopathy Type 46.
Test Details: The GRIN2D gene is associated with Early Infantile Epileptic Encephalopathy Type 46 (EIEE46), which is a rare genetic disorder characterized by seizures that begin in the first few months of life. NGS genetic testing can detect mutations in the GRIN2D gene that may be responsible for this disorder. This test can help diagnose EIEE46 and provide information about the risk of passing the condition on to offspring. Treatment for EIEE46 is focused on managing seizures and may include medications, dietary changes, and other therapies.
Test Name | GRIN2D Gene Early infantile epileptic encephalopathy type 46 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GRIN2D Gene Early infantile epileptic encephalopathy type 46 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GRIN2D Gene Early infantile epileptic encephalopathy type 46 |
Test Details | The GRIN2D gene is associated with Early Infantile Epileptic Encephalopathy type 46 (EIEE46), which is a rare genetic disorder characterized by seizures that begin in the first few months of life. NGS genetic testing can detect mutations in the GRIN2D gene that may be responsible for this disorder. This test can help diagnose EIEE46 and provide information about the risk of passing the condition on to offspring. Treatment for EIEE46 is focused on managing seizures and may include medications, dietary changes, and other therapies. |